Blueprint Medicines Corp (BPMC)
89.26
-1.24
(-1.37%)
USD |
NASDAQ |
Mar 13, 10:18
Blueprint Medicines Profit Margin (Quarterly): -34.13% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 16.72% |
| Eli Lilly and Co | 32.59% |
| Alnylam Pharmaceuticals Inc | -14.12% |
| Palatin Technologies Inc | -- |
| Vertex Pharmaceuticals Inc | 31.35% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.43% |
| Return on Assets | -5.92% |
| Return on Invested Capital | -11.14% |
| Gross Profit Margin (Quarterly) | 94.91% |
| Operating Margin (Quarterly) | -28.15% |
| Return on Net Operating Assets | -34.66% |